HIV-1感染男性精液中的抗逆转录病毒药物浓度。
Antiretroviral drug concentrations in semen of HIV-1 infected men.
作者信息
Taylor S, Pereira A S
机构信息
Division of Immunity and Infection, University of Birmingham, Birmingham Heartlands Hospital, UK.
出版信息
Sex Transm Infect. 2001 Feb;77(1):4-11. doi: 10.1136/sti.77.1.4.
Abstract
Because semen is a major vehicle for the sexual transmission of HIV-1, control of viral replication within the sanctuary of the male genital tract should be a goal of antiretroviral therapy. Local immune responses, virus specific factors, and the degree of viral and cellular trafficking all appear to be important in controlling viral replication and evolution. However, the most important factor influencing viral replication and evolution within the male genital tract may be the disposition of antiretroviral agents into genital tissues and fluids. This review proposes possible mechanisms of antiretroviral distribution into the male genital tract by using other sanctuary barriers; such as the placenta, renal tubules, and blood-brain barrier; as models. In addition, this review summarises recent clinical studies regarding the disposition of currently available antiretroviral drugs into the seminal plasma and discusses some of the difficulties in interpreting drug concentration in the genital tract.
摘要
由于精液是HIV-1性传播的主要载体，控制男性生殖道这个“庇护所”内的病毒复制应是抗逆转录病毒疗法的目标。局部免疫反应、病毒特异性因子以及病毒和细胞的转运程度似乎在控制病毒复制和进化方面都很重要。然而，影响男性生殖道内病毒复制和进化的最重要因素可能是抗逆转录病毒药物在生殖组织和体液中的分布情况。本综述通过将其他“庇护所”屏障（如胎盘、肾小管和血脑屏障）作为模型，提出抗逆转录病毒药物在男性生殖道内分布的可能机制。此外，本综述总结了近期关于现有抗逆转录病毒药物在精浆中分布情况的临床研究，并讨论了解释生殖道内药物浓度时的一些困难。
相似文献
1
Antiretroviral drug concentrations in semen of HIV-1 infected men.HIV-1感染男性精液中的抗逆转录病毒药物浓度。
Sex Transm Infect. 2001 Feb;77(1):4-11. doi: 10.1136/sti.77.1.4.
2
Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis.男性生殖道中抗逆转录病毒药物对HIV-1的定量分析：当前数据、局限性及对实验室分析的意义
J Pharm Pharmacol. 2007 Nov;59(11):1451-62. doi: 10.1211/jpp.59.11.0001.
3
Penetration of didanosine in semen of HIV-1-infected men.去羟肌苷在HIV-1感染男性精液中的渗透情况。
J Antimicrob Chemother. 2006 Jun;57(6):1244-7. doi: 10.1093/jac/dkl111. Epub 2006 Mar 23.
4
Pathophysiology of HIV-1 in semen: current evidence for compartmentalisation and penetration by antiretroviral drugs.HIV-1在精液中的病理生理学：抗逆转录病毒药物分区化和渗透的当前证据
Curr HIV Res. 2005 Jul;3(3):207-22. doi: 10.2174/1570162054368039.
5
[The male genital tract: A host for HIV].[男性生殖道：HIV的宿主]
Gynecol Obstet Fertil. 2007 Dec;35(12):1245-50. doi: 10.1016/j.gyobfe.2007.09.017. Epub 2007 Nov 26.
6
Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine.在单独使用一线洛匹那韦/利托那韦或联合齐多夫定/拉米夫定治疗1年后，男性生殖道中未检测到HIV-1脱落。
J Antimicrob Chemother. 2008 Jun;61(6):1344-7. doi: 10.1093/jac/dkn098. Epub 2008 Mar 13.
7
Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.高效抗逆转录病毒治疗期间精液、尿道及男性生殖器官中猴免疫缺陷病毒的检测
J Virol. 2015 Jun;89(11):5772-87. doi: 10.1128/JVI.03628-14. Epub 2015 Apr 1.
8
Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.恩夫韦肽、替诺福韦、依非韦伦及蛋白酶抑制剂在HIV-1感染男性生殖道中的渗透情况。
AIDS. 2004 Sep 24;18(14):1958-61. doi: 10.1097/00002030-200409240-00014.
9
Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma.比较精液和血浆中 HIV-1 病毒载量和抗逆转录病毒药物浓度的不协调性。
HIV Med. 2009 Oct;10(9):548-54. doi: 10.1111/j.1468-1293.2009.00725.x. Epub 2009 Jun 8.
10
Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.男性生殖道真的是HIV的庇护所吗？对此持否定观点的论据。
AIDS. 2004 Jul 2;18(10):1353-62. doi: 10.1097/01.aids.0000125979.64033.96.
引用本文的文献
1
Testis Is a Sanctuary Site for HIV-1.睾丸是HIV-1的庇护所。
Adv Exp Med Biol. 2025;1469:433-440. doi: 10.1007/978-3-031-82990-1_19.
2
Sexually transmitted doping: The impact of urine contamination of semen.性传播兴奋剂：精液尿液污染的影响。
Drug Test Anal. 2022 Sep;14(9):1623-1628. doi: 10.1002/dta.3331. Epub 2022 Jun 9.
3
Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo.来自感染 HIV-1 的个体的精液细胞外囊泡在体外抑制 HIV-1 复制，并且细胞外囊泡在体内携带抗逆转录病毒药物。
J Acquir Immune Defic Syndr. 2020 Jan 1;83(1):90-98. doi: 10.1097/QAI.0000000000002233.
4
Effect of monotherapy with darunavir/cobicistat on viral load and semen quality of HIV-1 patients.达芦那韦/考比司他单药治疗对 HIV-1 患者病毒载量和精液质量的影响。
PLoS One. 2018 Apr 24;13(4):e0196257. doi: 10.1371/journal.pone.0196257. eCollection 2018.
5
Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.抗逆转录病毒疗法与酒精的相互作用：透视高效抗逆转录病毒治疗时代的睾丸和精液参数
Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):121-135. doi: 10.1007/s13318-017-0438-6.
6
Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.接受有效抗逆转录病毒治疗的患者精液中残留HIV-1 RNA脱落模式。
Basic Clin Androl. 2017 Sep 8;27:17. doi: 10.1186/s12610-017-0063-x. eCollection 2017.
7
Uptake of tenofovir and emtricitabine into non-monocytic female genital tract cells with and without hormonal contraceptives.在有和没有激素避孕药的情况下，替诺福韦和恩曲他滨在非单核细胞女性生殖道细胞中的摄取情况。
J Exp Pharmacol. 2013 Aug 1;5:55-64. doi: 10.2147/JEP.S45308. eCollection 2013.
8
Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy.接受联合抗逆转录病毒治疗的血浆病毒载量检测不到的患者间歇性精液HIV-1 RNA脱落的时间
PLoS One. 2014 Mar 3;9(3):e88922. doi: 10.1371/journal.pone.0088922. eCollection 2014.
9
Characterization of binding of raltegravir to plasma proteins.拉替拉韦与血浆蛋白结合的特性分析。
Antimicrob Agents Chemother. 2013 Oct;57(10):5147-50. doi: 10.1128/AAC.00625-13. Epub 2013 Jul 15.
10
HIV treatment as prevention and HPTN 052.HIV 治疗即预防和 HPTN 052。
Curr Opin HIV AIDS. 2012 Mar;7(2):99-105. doi: 10.1097/COH.0b013e32834f5cf2.
本文引用的文献
1
Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.HIV-1感染男性精液中奈韦拉平、拉米夫定和司他夫定的浓度。
AIDS. 2000 Sep 8;14(13):1979-84. doi: 10.1097/00002030-200009080-00014.
2
Semen and serum pharmacokinetics of zidovudine and zidovudine-glucuronide in men with HIV-1 infection.齐多夫定及其葡萄糖醛酸苷在HIV-1感染男性中的精液和血清药代动力学
Pharmacotherapy. 2000 Aug;20(8):917-22. doi: 10.1592/phco.20.11.917.35263.
3
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.添加低剂量利托那韦后茚地那韦在脑脊液和精液中的渗透性增强。
AIDS. 2000 Jun 16;14(9):1187-94. doi: 10.1097/00002030-200006160-00016.
4
Antiretroviral-drug concentrations in semen.精液中的抗逆转录病毒药物浓度。
Antimicrob Agents Chemother. 2000 Apr;44(4):1117-8. doi: 10.1128/AAC.44.4.1117-1118.2000.
5
Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma.无症状性尿道炎与精液中HIV-1 RNA的检测
Sex Transm Infect. 1999 Aug;75(4):261-3. doi: 10.1136/sti.75.4.261.
6
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.拉米夫定在感染HIV-1患者外周血单核细胞中的磷酸化药代动力学。
AIDS. 1999 Nov 12;13(16):2239-50. doi: 10.1097/00002030-199911120-00006.
7
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.核苷类似物在精浆中可达到高浓度：药物浓度与病毒载量之间的关系。
J Infect Dis. 1999 Dec;180(6):2039-43. doi: 10.1086/315149.
8
The effect of increasing alpha1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors.
J Infect Dis. 1999 Dec;180(6):1833-7. doi: 10.1086/315123.
9
Reduced antiretroviral drug susceptibility among patients with primary HIV infection.原发性HIV感染患者中抗逆转录病毒药物敏感性降低。
JAMA. 1999;282(12):1142-9. doi: 10.1001/jama.282.12.1142.
10
HIV-1 drug resistance in newly infected individuals.新感染个体中的HIV-1耐药性。
JAMA. 1999;282(12):1135-41. doi: 10.1001/jama.282.12.1135.
Zotero 插件